News
The IC2PerMed summarized version of the roadmap is now online
We are delighted to announce that the summary version of the IC2PerMed Roadmap has been published. You [...]
IC2PerMed partners gathered in China to sign a MoU for extending Sino-EU collaboration in Personalised Medicine
From 21 to 23 October 2023, in the framework of the IC2PerMed project, the second IC2PerMed delegation [...]
IC2PErMed new publication in Open Access Government Journal – Check it out !
We are happy to announce that IC2PerMed’s article “Fostering collaboration between Europe and China to enhance Personalised Medecine" [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.
